2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

[1]  P. Leprince,et al.  Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry. , 2016, Journal of the American College of Cardiology.

[2]  Sean M. O'Brien,et al.  Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry , 2016, Circulation. Cardiovascular quality and outcomes.

[3]  B. Whisenant,et al.  Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. , 2016, JACC. Cardiovascular interventions.

[4]  Sean M. O'Brien,et al.  Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. , 2016, JAMA cardiology.

[5]  S. Kapadia,et al.  Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States. , 2016, Journal of the American College of Cardiology.

[6]  J. Carroll,et al.  Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2016, The Annals of thoracic surgery.

[7]  Deepak L. Bhatt,et al.  Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. , 2015, The New England journal of medicine.

[8]  R. Lange,et al.  Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. , 2015, Journal of the American College of Cardiology.

[9]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[10]  M. Mack,et al.  Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2015, JACC. Cardiovascular interventions.

[11]  Tamara Syrek Jensen,et al.  Transcatheter valve therapy registry is a model for medical device innovation and surveillance. , 2015, Health affairs.

[12]  Sean M. O'Brien,et al.  Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.

[13]  Danica Marinac-Dabic,et al.  The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.

[14]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[15]  K. Chartikavanij Aortic valve replacement. , 1969, Israel journal of medical sciences.